Quinine plus clindamycin improves chemotherapy of severe malaria in children.
AUTOR(ES)
Kremsner, P G
RESUMO
In a randomized trial, a 4-day quinine-clindamycin regimen was compared with the standard 7-day quinine regimen for 100 Gabonese children (50 children in each group) with severe Plasmodium falciparum malaria. In each group, only one patient died. Parasite clearance and fever clearance times were significantly shorter in the quinine-clindamycin group (P = 0.03 and P = 0.01, respectively) than in the quinine group, and significantly more recurring fever episodes occurred in the quinine group than in the quinine-clindamycin group shortly after initial fever clearance and parasite clearance (P < 0.001).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162790Documentos Relacionados
- Population Pharmacokinetics of Intramuscular Quinine in Children with Severe Malaria
- Therapeutic Responses to Quinine and Clindamycin in Multidrug-Resistant Falciparum Malaria
- Three-Day Quinine-Clindamycin Treatment of Uncomplicated Falciparum Malaria Imported from the Tropics
- High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria.
- Ciprofloxacin for treatment of severe typhoid fever in children.